• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Apopharma`s Generics Rivaroxaban Receives Tentative Approval in US

    FDA

    Apopharma`s Generic Apremilast Receives Approval in the U.S.

    FDA

    Patent Challenges for ApoPharma’s Ferriprox and Akorn’s Zioptan

    TWOFOUR INSIGHT

    ApoPharma Announces Health Canada Approval of Ferriprox (deferiprone)

    APOTEX

    Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Filgrastim (Grastofil™)

    APOTEX

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.